Abstract

In this paper, new porous pH-responsive microspheres based on functionalized halloysite nanotubes (HNTs) with poly-lactic-co-glycolic acid (PLGA) are investigated as the phenytoin sodium (PHT-Na) carrier. For this purpose, the surfaces of HNTs were modified by a silane coupling agent, (3-aminopropyl)triethoxysilane (APTES) and then the desired microsphere was synthesized through PLGA coating on modified HNTs. Formation of these hybrid particles are confirmed using various characterization methods like Fourier transform infrared (FT-IR), transmission electron microscope (TEM), scanning electron microscope (SEM), EDX, zeta-potential, and X-ray diffraction. The results of the FT-IR spectrum show the presence of APTES, PHT-Na and PLGA peaks, which supported the modification of HNTs and drug capsulation. TEM images confirm the presence of APTES on HNTs, due to the increase in outer diameter. SEM images displayed that by grafting PLGA polymer to modified HNTs, the shape of nanotubes has changed from rod-like to microsphere. Hence, the prospering connection of APTES and PLGA on HNTs was emphasized by zeta-potential results. Moreover, the profile of drug release is recorded via HPLC. In vitro drug release tests show that both the presence of polymer chains around drug containers and the pH value of the release medium play an important role in controlled release. Eventually, the kinetics of drug release was evaluated based on Korsmeyer–Peppas kinetic model.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.